Abstract-Our long-term objective is to identify genes whose expression results in hypertension and in phenotypic changes that may contribute to hypertension. The purpose of the present study was to describe evidence for the heritability of hypertension-related phenotypes in hypertensive, hyperlipidemic black sib pairs. Outpatient anthropomorphic measurements were obtained in Ͼ200 affected sib pairs. In addition, 68 of these sib pairs were studied under controlled, standardized conditions at an inpatient clinical research center while off both antihypertensive and lipid-lowering medications. Heritability was estimated on the basis of sib-sib correlations and with an association model. Higher heritability estimates for blood pressure were observed with multiple measurements averaged over 24 hours than with measurements at a single time point, and heritability estimates for nighttime blood pressures were higher than those for daytime blood pressures. Heritability estimates for several of the phenotypes were augmented by obtaining measurements in response to a standardized stimulus, including (1) blood pressure responses to the assumption of upright posture, standardized psychological stress, and norepinephrine infusion; (2) plasma renin, aldosterone, epinephrine, and cAMP and cGMP responses to the assumption of upright posture; (3) para-aminohippurate and inulin clearances in response to norepinephrine infusion; and (4) plasma arginine vasopressin in response to NaCl infusion. High heritability estimates were also observed for various measures of body size and body fat, left ventricular size, cardiac index, stroke volume, total peripheral resistance, and serum concentrations of LDL and HDL cholesterol and leptin. These heritability estimates identify the hypertension-related phenotypes that may facilitate the identification of specific genetic determinants of hypertension in blacks with hyperlipidemia. (Hypertension. 2000;36:7-13.)
A doption, twin, and family studies document a significant heritable component to blood pressure levels and hypertension. [1] [2] [3] Estimates of the heritability of resting systolic and diastolic blood pressures, based on family studies, are generally in the range of 15% to 35%. In twin studies, heritability estimates of blood pressure are Ϸ60% for males and Ϸ30% to 40% for females. 2 A heritable component to salt sensitivity of blood pressure has been described in blacks. 4 A large proportion of the phenotypic variation in blood pressure appears to be inherited as a polygenic trait. 5, 6 Our long-term objective is to identify genetic loci and specific genes whose expression results in hypertension and in phenotypic changes that may contribute to hypertension.
Blacks are one focus of our studies. In the United States, the prevalence of hypertension is 50% greater in blacks than in whites. 7 In blacks, hypertension appears earlier, is generally more severe, and results in high rates of morbidity and mortality from stroke, heart failure, left ventricular hypertrophy, and end-stage renal disease. 8 -11 Both genetic and environmental factors may contribute to the higher prevalence of hypertension in blacks. 12 In addition, a genetic contribution to the increased prevalence of renal disease among hypertensive blacks has been proposed on the basis of family studies and studies of associated histocompatibility antigens. [13] [14] [15] To further narrow genetic heterogeneity, we have chosen to study a subset of blacks with both hypertension and elevated serum cholesterol levels. Family studies suggest that the phenotype of hypertension in combination with elevated cholesterol is heritable and is associated with accelerated cardiovascular disease. 16 -18 Because gene/environment interactions may obscure the expression of a heritable phenotype, to exclude the potential for incomplete penetrance, we are studying black sib pairs in which each sib has both hypertension and hypercholesterolemia.
We are investigating several physiological pathways through which mutations may act to increase blood pressure. The selection of specific hypertension-associated phenotypes for the study was based on their potential relevance to the pathogenesis of hypertension and cardiovascular disease, previous evidence of heritability, and feasibility of obtaining standardized measurements in relatively large numbers of subjects. The purpose of the present study was to describe evidence for heritability of a number of phenotypes that may contribute to elevated arterial pressure in hypertensive, hypercholesterolemic blacks. The identification of heritable, hypertension-related phenotypes will facilitate the identification of specific genetic determinants of hypertension.
Methods
Consenting black sib pairs, aged 18 to 55 years, with essential hypertension and elevated total serum cholesterol concentrations were potential candidates for study. Multiple strategies were used for the recruitment of affected sib pairs. Approximately 50% of the studied patients were recruited from clinics associated with the Medical College of Wisconsin or other inner-city clinics in Milwaukee. In addition, recruitment materials were sent to the 90 000 black age-eligible registered drivers in Milwaukee. The letters contained an explanation of the project, and interested individuals were asked to return a brief questionnaire for information to assess potential eligibility for inclusion in the study (including age, history of hypertension, and availability of siblings for study). The response rate for this direct mailing was 2.6%, with Ϸ4% of respondents meeting the study eligibility requirements. Additional recruitment strategies included contacts through black organizations, particularly churches, newspapers, and radio and television.
Potentially eligible subjects were invited to a screening clinic visit. Subjects were considered to have hypertension if standardized measurements of blood pressure were Ͼ140/90 mm Hg on 2 occasions or if they were taking antihypertensive medications. Screening measurements also included nonfasting serum cholesterol, serum creatinine, and serum glucose levels. Elevated cholesterol was defined as serum cholesterol of Ͼ200 mg/dL or current use of lipid-lowering medications. A careful family history was taken to ascertain full sibling relationships. Exclusion criteria included diabetes mellitus, serum creatinine concentration of Ͼ2.2 mg/dL, substance abuse (including alcohol), and half-sib relatives. In qualifying sib pairs, venous blood samples were obtained to extract DNA from leukocytes for a future total genomic scan, and the following anthropomorphic measurements were obtained: height, weight, waist and hip circumferences, and skinfold thicknesses at multiple sites.
Eligible sib pairs were subsequently considered potential candidates for a 2-day inpatient protocol for additional phenotypic measurements. Before subjects were selected for the inpatient study, a detailed history was obtained and a physical examination was performed. Additional exclusion criteria for the inpatient study included diastolic blood pressure of Ͼ110 mm Hg while receiving drug therapy, body mass index of Ͼ34 kg/m 2 , pregnancy, malignancy, and myocardial infarction or stroke within 6 months. Before the inpatient study, antihypertensive drugs were withdrawn for at least 1 week, and lipid-lowering medications were withdrawn for 1 month. Separate informed consent forms were signed by all subjects for the outpatient and inpatient protocols. Each subject received a $25 stipend for outpatient testing and a $200 stipend for completing the inpatient studies. The protocols were approved by the Medical College of Wisconsin Human Research Review Committee, and all procedures were in accordance with institutional guidelines.
For the inpatient studies, sib pairs were admitted to a Clinical Research Center for 2 days, beginning the afternoon before day 1 of the protocols, and were placed on a weight-maintaining 150 mEq Na ϩ /80 mEq K ϩ diet. On day 1, intravenous catheters were inserted in both arms: 1 for blood sampling and 1 for infusions. Baseline measurements included standardized measurements of blood pressure, a 2-dimensional echocardiogram, and fasting measurements of lipid concentrations, glucose, and insulin. Fasting blood, anticoagulated with heparin, was also obtained to measure red blood cell Na ϩ -Li ϩ countertransport and Na ϩ -K ϩ cotransport. Subsequently, in a quiet room with minimal patient interruptions, the following were measured after subjects had been supine for 60 minutes and again after they stood for 10 minutes: repeated standardized measurements of blood pressure, cardiac output, and stroke volume and measurements of plasma renin activity and plasma aldosterone, plasma norepinephrine and epinephrine, cAMP, and cGMP. Hemodynamic measurements were repeated after subjects had been sitting quietly for 30 minutes and again after a 2-minute mental "stress test," in which subjects were asked to rapidly solve a progressively more difficult series of arithmetic problems. 19 Blood pressure was measured with an automated device (Dinamap; Johnson & Johnson Medical, Inc), and cardiac output and stroke volume were measured with impedance plethysmography (Sorba Medical Systems, Inc). Cardiac index was computed as cardiac output/body surface area, and total peripheral resistance was computed as mean arterial pressure/cardiac output. After completion of these protocols, insulin sensitivity was assessed with the reduced sampling method of the Bergman minimal model with insulin injection. 20 The insulin sensitivity index (S i ) was determined with use of the MINMOD computer program of Bergman. In addition, beginning on day 1 for a 24-hour period, blood pressure was measured every 20 minutes during the day and every 45 minutes during the night with an Accutracker II monitor (Sun Tech Medical Instruments, Inc).
On day 2, blood pressure, renal blood flow (PAH clearance), and glomerular filtration rate (inulin clearance) were measured in response to 2 infusion rates of norepinephrine (0.01 and 0.025 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) for 30 minutes each, as we previously described. 21 In conjunction with these clearance measurements, patients received an oral water load of 15 mL/kg and then 850 mL of normal saline IV over the ensuing 6 hours. Plasma arginine vasopressin (AVP) concentrations were measured before and after the fluid challenge. Also on day 2, lithium clearance was determined with the administration of 600 mg lithium carbonate PO at 11 PM on the night before and the measurement of plasma and 2-hour urine lithium excretion.
Estimates of heritability for each of the phenotypes were derived with 2 different approaches. The first approach involved computation of sib-sib correlations with the program FCOR in the S.A.G.E. software package. A sib-sib correlation for each phenotype was calculated, with equal weight assigned to every pair. Twice, the sib-sib correlation was used as an estimate of heritability of a phenotype. The second approach involved the use of the ASSOC program in the S.A.G.E. package. The primary purpose of this program is to analyze the association between a quantitative phenotype and a discrete marker with a mixed-effect model proposed by George and Elston 22 and Elston et al. 23 The model treats the covariates as fixed effects and the familial effect among relatives as a random effect (g), in addition to the random individual-specific environmental effect (e). The familial effect is modeled on the assumption that the phenotypic correlations between pairs of family members are entirely due to polygenic inheritance. On the basis of this assumption, estimates of the familial and the environmental components of the total phenotypic variance are computed with other estimates of the parameters in the model through iterative maximization of the likelihood function. Heritability is computed as the ratio of the familial component of the variance (V g ) to the total variance (V g ϩV e ). The program computes the variance of the estimates of the genetic (V v(g) ) and environmental [V v(e) ] components of the variance. It also computes the covariance (COV) between these components. The delta method was used to derive the asymptotic standard error of heritability from these estimates. The estimate of heritability (h 2 ) and its standard error (SE), thus derived, are computed as follows:
This estimate of heritability was adjusted for age and gender when there was a significant association with a phenotype. Heritability estimates of left ventricular mass and hemodynamic, renal, and neurohormonal phenotypes were also adjusted for body mass index, and heritability estimates for measures of left ventricular mass were adjusted for blood pressure. With this model, in several instances the heritability estimates converged to the lower boundary of zero, and hence no standard error was computed.
Results
The format for each of the tables is identical. For each phenotype, the number of "affected" sib pairs studied is included. The numbers vary because not all protocols were carried out in all subjects. Outpatient measurements were obtained in more subjects than the inpatient phenotypic studies. The tables also present the meanϮSE value for each phenotype, 2 times the sib-sib correlation (2ϫr) as 1 estimate of heritability, and an additional estimate of heritability based on the association model (h 2 ϮSE). For the heritability estimates based on sib-sib correlations, the levels of statistical significance refer to the correlations between sib pairs for each of the phenotypes. For the association model, levels of statistical significance refer to the likelihood that the heritability estimate differs from zero.
In general, there was a close correspondence between the estimates of heritability derived from the sib-sib correlations and those derived from the association model. The mean age of the sib pairs was 46 years Ϯ1 SE. The study population was relatively obese, with an average body mass index of 33.0 kg/m 2 ( Table 1) . Heritability estimates for body measurements ranged from 0.30 to 0.76. Higher estimates of heritability were observed for skinfold thicknesses, measured at several sites, and for percent body fat determined from skinfold thickness.
On the basis of 24-hour blood pressure monitoring, average nighttime systolic and diastolic blood pressures were lower (PϽ0.01) than daytime blood pressures (Table 2) . After subjects were standing for 10 minutes, systolic blood pressure did not change and diastolic blood pressure increased compared with respective supine values (PϽ0.01). Systolic and diastolic blood pressures increased (PϽ0.01 and Ͻ0.05, respectively) in response to the math "stress" test, and both systolic and diastolic blood pressures also increased (PϽ0.01) in response to norepinephrine infusions. Heritability estimates for diastolic blood pressure tended to be greater than those for systolic blood pressure (Table 2 ). Higher estimates of heritability were observed with average blood pressure levels based on 24-hour blood pressure monitoring than those based on resting measurements at any 1 point in time. Heritability estimates of nighttime blood pressures were higher than estimates based on blood pressures measured during the day. In contrast, heritability estimates for heart rate were greater during the day than at night. Heritability estimates for blood pressure were also augmented by acute blood pressure change in response to upright posture, by blood pressure responses to a standardized math stress test, and by response to the infusion of norepinephrine.
Compared with supine values, cardiac index and stroke volume decreased (PϽ0.01) and total peripheral resistance increased in subjects in the sitting position (PϽ0.01). Relatively high heritability estimates were observed for cardiac index, stroke volume, total peripheral resistance, and left ventricular size.
During norepinephrine infusion, inulin clearance increased (PϽ0.05) and PAH clearance did not change compared with respective baseline values ( Table 3) . Heritability estimates for both inulin and PAH clearances were higher during norepinephrine infusion than at baseline. Our data do not demonstrate evidence for heritability of either lithium clearance or fractional lithium excretion. Compared with respective supine values, plasma renin activity, aldosterone, norepinephrine, epinephrine, and cAMP all increased (PϽ0.01) in subjects in the standing position. Significant estimates of heritability were observed for renin, norepinephrine, epinephrine, and cAMP but not for plasma aldosterone. Heritability estimates for renin, epinephrine, cAMP, and cGMP were augmented by upright posture. Significant heritability for AVP was observed after, but not before, saline infusion. High heritability estimates were also observed for fasting plasma concentrations of leptin and HDL and LDL cholesterol, but not for apoA or apoB, triglycerides, insulin, glucose, or the insulin sensitivity index.
Discussion
The primary aim of the present report was to identify hypertension-related phenotypes in blacks that are most likely to have a genetic basis and hence merit inclusion in studies designed to identify the specific genetic determinants of hypertension. Previous family studies suggest evidence for a heritable component to several hypertension-related phenotypes evaluated in the present protocols: obesity and body mass index, dyslipidemia and insulin resistance, left ventricular mass, and responsivity to pressor stimuli. 17,18,24 -28 In addition, there is equivocal, sometimes conflicting evidence for familial resemblance of blood pressure responses to psychological stress (including mental arithmetic) and upright posture, lithium clearance and renal blood flow, Na ϩ -Li ϩ countertransport, Na ϩ -K ϩ cotransport, and plasma renin and aldosterone, plasma catecholamine, and plasma leptin concentrations. 24,29 -35 These earlier observations, obtained primarily in white subjects, influenced the selection of phenotypes evaluated in the present study. The current report extends these observations to hypertensive-hyperlipidemic blacks and defines the optimum study conditions for the detection of evidence of heritability. For ethical reasons, we did not withhold antihypertensive drug therapy for Ͼ2 weeks, 
Kotchen et al Candidate Hypertension-Related Phenotypes
and we cannot exclude a potential residual effect of prior antihypertensive drugs on some of the phenotypes. However, it is unlikely that prior drug therapy would result in spuriously high estimates of heritability.
Blood pressure is a difficult phenotype because of its considerable variability. In previous population studies, sibsib blood pressure correlations have been in the range of 0.14 to 0.18. 3 Similarly, in this black group of hypertensive individuals, sib-sib correlations for systolic and diastolic blood pressures, off of antihypertensive drug therapy, were generally within this range, even when these measurements were obtained at an inpatient clinical research center under standardized conditions. Compared with measurements at 1 point in time, higher heritability estimates were generally observed when multiple blood pressure measurements obtained over 24 hours were averaged. Heritability estimates for average nighttime blood pressures were higher than those for daytime blood pressures, possibly due to minimization or exclusion of random daytime fluctuations of blood pressure related to uncontrolled environmental stimuli. Furthermore, our results demonstrate evidence for heritability of the determinants of arterial pressure (cardiac output and total peripheral resistance) and of cardiac output (heart rate and stroke volume).
Our observations also suggest that a genetic contribution to blood pressure level and to several hypertension-related 
phenotypes is more readily detectable by obtaining these measurements in response to a standardized stimulus. Among the highest heritability estimates for blood pressure were those observed in response to the assumption of upright posture, standardized psychological stress, and norepinephrine infusion. The assumption of upright posture also augmented heritability estimates for plasma renin activity, plasma epinephrine, and plasma cAMP and cGMP concentrations. Evidence for heritability of PAH and inulin clearances became apparent only in response to the standardized stimulus of norepinephrine-induced acute elevations of blood pressure. In addition, significant heritability estimates for AVP were observed after the infusion of NaCl but not before. High estimates of heritability were observed for various measures of body size and body fat, which is consistent with the hypothesis that hypertension and overweight constitute shared components of a familial syndrome. However, our data do not provide support for the heritability of insulin resistance as measured with the Bergman minimal model. This may be related to the fact that a high degree of insulin resistance was observed in this obese population, as determined by the low S i,, and the clustering of low S i values may have obscured evidence for familiality. Alternatively, the familial syndrome of hypertension associated with insulin resistance may be less prominent in blacks than in whites. 36 Ideally, an estimate of heritability based on the association model would be approximately the same as that derived by multiplying the sib-sib correlation estimate by 2. For most of the traits evaluated in this study, heritability estimates obtained with the 2 methods are consistent. Apparent discrepancies in estimates between the 2 methods may be due to relatively small sample sizes and to adjustment for significantly related covariates in the association model. Nevertheless, defining "heritability" on the basis of phenotypic similarities between siblings has limitations. The validity of both estimates of heritability requires random mating, gametic phase equilibrium, the absence of a dominant genetic effect, the absence of epistatic genetic variance, and the absence of common environmental effects. The potential for exposure to a shared environment among sibs may result in an overestimate of heritability. Conversely, in the present study, assessments of sibling relationships were based on interview responses, and some of the pairs may not be full siblings. This would decrease our estimates of heritability. Furthermore, the ascertainment of our sample from the population with hypertension and elevated serum cholesterol may make our estimates applicable to only that subset of the population.
Definitive evidence for heritability will depend on linking hypertension-related phenotypes to specific variations in the genome. The heritability estimates provided in the present study identify those phenotypes for which a specific genetic basis is likely to be found in future studies of the genetic determinants of hypertension in blacks.
